175 related articles for article (PubMed ID: 29251334)
1. Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3.
Li X; Yang Z; Han Z; Wen Y; Ma Z; Wang Y
Oncol Rep; 2018 Feb; 39(2):827-833. PubMed ID: 29251334
[TBL] [Abstract][Full Text] [Related]
2. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
Li X; Ding R; Han Z; Ma Z; Wang Y
Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
[TBL] [Abstract][Full Text] [Related]
3. Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family.
Suliman MA; Zhang Z; Na H; Ribeiro AL; Zhang Y; Niang B; Hamid AS; Zhang H; Xu L; Zuo Y
Int J Mol Med; 2016 Sep; 38(3):776-84. PubMed ID: 27460529
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
Liu W; Lv C; Zhang B; Zhou Q; Cao Z
RNA; 2017 Jul; 23(7):1019-1027. PubMed ID: 28396577
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway.
Zhu Y; Zuo W; Chen L; Bian S; Jing J; Gan C; Wu X; Liu H; Su X; Hu W; Guo Y; Wang Y; Ye T
Biochem Pharmacol; 2019 Nov; 169():113610. PubMed ID: 31465777
[TBL] [Abstract][Full Text] [Related]
6. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152.
Wang Y; Wang S; Wu Y; Ren Y; Li Z; Yao X; Zhang C; Ye N; Jing C; Dong J; Zhang K; Sun S; Zhao M; Guo W; Qu X; Qiao Y; Chen H; Kong L; Jin R; Wang X; Zhang L; Zhou J; Shen Q; Zhou X
Mol Cancer Ther; 2017 Apr; 16(4):578-590. PubMed ID: 28138036
[TBL] [Abstract][Full Text] [Related]
8. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
Han H; Du L; Cao Z; Zhang B; Zhou Q
Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
[TBL] [Abstract][Full Text] [Related]
9. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
Zhou X; Ren Y; Liu A; Han L; Zhang K; Li S; Li P; Li P; Kang C; Wang X; Zhang L
Oncol Rep; 2014 May; 31(5):2173-80. PubMed ID: 24676554
[TBL] [Abstract][Full Text] [Related]
10. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
11. The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model.
Ye T; Xiong Y; Yan Y; Xia Y; Song X; Liu L; Li D; Wang N; Zhang L; Zhu Y; Zeng J; Wei Y; Yu L
PLoS One; 2014; 9(1):e85887. PubMed ID: 24416452
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP.
Zhu W; Sun W; Zhang JT; Liu ZY; Li XP; Fan YZ
Int J Oncol; 2015 Feb; 46(2):627-40. PubMed ID: 25405519
[TBL] [Abstract][Full Text] [Related]
13. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
Cheng R; Cai XR; Ke K; Chen YL
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
[TBL] [Abstract][Full Text] [Related]
14. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
[TBL] [Abstract][Full Text] [Related]
15. Effects of miR‑93 on epithelial‑to‑mesenchymal transition and vasculogenic mimicry in triple‑negative breast cancer cells.
An G; Lu F; Huang S; Bai J; He L; Liu Y; Hou L
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179106
[TBL] [Abstract][Full Text] [Related]
16. The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer.
Sun Q; Zou X; Zhang T; Shen J; Yin Y; Xiang J
Gynecol Oncol; 2014 Mar; 132(3):730-8. PubMed ID: 24503464
[TBL] [Abstract][Full Text] [Related]
17. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
18. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
19. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
[TBL] [Abstract][Full Text] [Related]
20. miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.
Zhang X; Tang J; Zhi X; Xie K; Wang W; Li Z; Zhu Y; Yang L; Xu H; Xu Z
Oncotarget; 2015 Jan; 6(3):1605-17. PubMed ID: 25596740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
